BioSpace News Archive

Drug Development

6 Companies Report Positive Data in Phase III Clinical Trials

Quite a few companies recently released results from late-stage clinical trials. Here’s a look at some of the top stories, from AveXis, Urovant, Lilly, and more.

May 6, 2019
·
5 min read
·
Mark Terry
FDA

Genentech’s Kadcyla Wins Second FDA Approval for HER2-Positive Breast Cancer

The FDA rapidly reviewed and approved the medication under the FDA’s Real-Time Oncology Review (RTOR) and Assessment Aid pilot program.

May 6, 2019
·
2 min read
·
Alex Keown
Business

Artificial Intelligence is Ramping up in Drug Development

AstraZeneca announced a long-term collaboration deal with BenevolentAI, a UK-based company focused on combining computational medicine and advanced artificial intelligence.This deal only marks one of the most recent AI team-ups announced in the biopharma industry.

May 6, 2019
·
5 min read
·
Mark Terry
Policy

Esperion Announces U.S. FDA Acceptance of New Drug Applications (NDAs) for Both Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet for Filing and Regulatory Review

Bempedoic Acid is an Oral, Once-daily ATP Citrate Lyase (ACL) Inhibitor that Reduces Cholesterol and Fatty Acid Synthesis in the Liver

May 6, 2019
·
8 min read
Deals

Invitrocue Releases March 2019 Quarterly And Appoints New Advisor

Invitrocue Limited is pleased to provide its Appendix 4C cash flow statement for the quarter ended March 31, 2019 and to announce the appointment of Dr Sharifuddin Abdul Wahab as Global Insurance Advisor.

May 6, 2019
·
1 min read
Adrenomed AG takes part in three upcoming conferences

Adrenomed AG, the vascular integrity company, announced its participation at three upcoming conferences in Europe and the USA.

May 6, 2019
·
1 min read
Biotech Bay

TLC Highlights Data Presentations on Lead Product Candidate TLC599 at Osteoarthritis Research Society International (OARSI) 2019 World Congress

TLC presented data from numerous recent studies on its lead product candidate, TLC599, at the Osteoarthritis Research Society International World Congress, which took place May 2 to 5, 2019 in Toronto, Canada.

May 6, 2019
·
4 min read
Deals

Banco Sabadell Gives ADL Bionatur Solutions An Upside Potential Of 78%

Sales estimated to double in 2019 and exceed EUR 50 million

May 6, 2019
·
2 min read
Publications of Secarna Pharmaceuticals’ immuno-oncology data in peer-reviewed scientific journals support potential of LNAplusTM antisense oligonucleotide platform for discovering novel cancer therapies

New strategies urgently needed to prevent tumors from evading the immune system and to make them more susceptible to attack by immune cells

May 6, 2019
·
6 min read
Pharm Country

Biotech Support Group to exhibit at the 67th ASMS Conference on Mass Spectrometry & Allied Topics

Biotech Support Group will exhibit at the annual ASMS Conference, June 2-6, 2019 in Atlanta, GA.

May 6, 2019
·
3 min read